Three Top Healthcare Stocks to Buy with $1,000 Right Now

Healthcare Sector Investment Opportunities. Many investors are turning to the healthcare sector, viewed as a safe haven during turbulent markets. Three recommended stocks to consider are AbbVie, Vertex Pharmaceuticals, and Kiniksa Pharmaceuticals, each showing growth potential.

Date: 14-03-2025

AI Rating: 7

Growth Opportunities in Healthcare Stocks

The report provides insights on three healthcare stocks that investors might consider, as these companies are performing well even in a challenging market environment.

AbbVie (NYSE: ABBV) is highlighted as a strong contender, with shares up around 20% year-to-date. The report notes impressive sales growth for its blockbuster drugs, particularly Rinvoq and Skyrizi, which are leading the market. The forward dividend yield of 3.09% and history of consecutive dividend increases support its standing as a desirable investment.

Vertex Pharmaceuticals (NASDAQ: VRTX) shows an even greater gain with shares also soaring more than 20% in the same timeframe. The company benefits from FDA approvals for two new drugs that are expected to drive its profit margins. The potential for expanded market share in its cystic fibrosis treatments adds to its attractiveness for investors.

Kiniksa Pharmaceuticals (NASDAQ: KNSA) is a newer player in the market yet sees solid performance with its flagship product, Arcalyst. Sales growth of 79% year-over-year emphasizes a promising future, particularly with projected sales reaching up to $580 million. Despite not yet being profitable, the market potential showcases its attractiveness as a long-term investment.

This report suggests that these stocks have unique strengths and are positioned to capitalize on growth opportunities. Given the solid performances noted, it may be prudent for investors to consider adding these stocks to their portfolios, particularly in a less stable economic climate.

Stocks: ABBV VRTX KNSA